Edition:
India

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

762.70INR
21 Sep 2018
Change (% chg)

Rs-13.25 (-1.71%)
Prev Close
Rs775.95
Open
Rs779.00
Day's High
Rs786.80
Day's Low
Rs698.40
Volume
4,395,912
Avg. Vol
3,381,236
52-wk High
Rs827.45
52-wk Low
Rs527.00

Chart for

About

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system,... (more)

Overall

Beta: 0.84
Market Cap(Mil.): Rs437,068.31
Shares Outstanding(Mil.): 585.88
Dividend: 1.25
Yield (%): 0.52

Financials

  ARBN.NS Industry Sector
P/E (TTM): 19.51 30.93 32.76
EPS (TTM): 38.23 -- --
ROI: -- 15.07 14.61
ROE: -- 16.59 16.33

Novartis unloads U.S. assets at loss to bargain-hunting Aurobindo

ZURICH/BENGALURU New Novartis Chief Executive Vas Narasimhan has further reshaped the Swiss drugmaker, announcing on Thursday he is selling U.S. dermatology and generic pill assets to India's Aurobindo Pharma Ltd for up to $1 billion.

06 Sep 2018

UPDATE 3-Novartis unloads U.S. assets at loss to bargain-hunting Aurobindo

* Deal to result in $70 mln impairment for Novartis (Adds related content, detail about impairment in third graf, updates shares)

06 Sep 2018

Novartis sells U.S. generics assets to bargain-hunting Aurobindo Pharma

ZURICH/BENGALURU New Novartis Chief Executive Vas Narasimhan has further reshaped the Swiss drugmaker, announcing on Thursday he is selling U.S. dermatology and generic pill assets to India's Aurobindo Pharma Ltd for up to $1 billion.

06 Sep 2018

BUZZ-India's Aurobindo Pharma rises, co to buy parts of Sandoz U.S. for $900 mln

** Aurobindo Pharma Ltd rises as much as 3.6 pct to 722 rupees

06 Sep 2018

Novartis sells parts of Sandoz US to India's Aurobindo for $900 mln

Sept 6 Novartis AG said on Thursday it would sell the dermatology and generic U.S. oral solids portfolios of Sandoz U.S. to India's Aurobindo Pharma Ltd for $900 million, as the Swiss drugmaker looks to focus on higher growth areas.

06 Sep 2018

Aurobindo Pharma first-quarter profit misses estimates

Aurobindo Pharma Ltd reported a 12 percent fall in quarterly profit on Thursday and missed analysts' expectations, hurt by higher expenses.

09 Aug 2018

India's Aurobindo Pharma Q1 profit misses estimates

Aug 9 Aurobindo Pharma Ltd reported a 12 percent fall in quarterly profit on Thursday and missed analysts' expectations, hurt by higher expenses.

09 Aug 2018

BUZZ-Apotex deal to help India's Aurobindo Pharma deepen EU presence - Citi

** Citi says Aurobindo Pharma Ltd's 74 mln euros ($86.6 mln) deal to buy some European businesses of Canadian firm Apotex International Ltd is part of inorganic strategy

16 Jul 2018

BUZZ-India's Aurobindo Pharma slips on Q4 miss

** Aurobindo Pharma Ltd plunges as much as 6.2 pct to 567.95 rupees, its lowest in a week

29 May 2018

Aurobindo Pharma fourth-quarter profit misses estimates

India's Aurobindo Pharma Ltd posted a 0.6 percent fall in fourth-quarter net profit on Monday that missed analysts' estimates.

28 May 2018

Earnings vs. Estimates